查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429514

2024 年注射給藥裝置全球市場報告

Injectable Drug Delivery Devices Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

注射給藥裝置的市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 6.8% 的複合年成長率 (CAGR) 成長至 617.8 億美元。預測期內的預期成長是由慢性病患病率增加、注射藥物需求增加、嚴重感染疾病突然出現以及處於不同臨床試驗階段的眾多藥物和疫苗等因素推動的。由於。預測期內預計的顯著趨勢包括重點開發基於微針的藥物輸送系統、投資於自行注射設備的研發、穿戴式設備的製造以及無針注射系統的生產，其中包括擴大的產品線包括了：我們專注於預填充式注射器，改進設備的數位技術，製造創新設備，製造創新自動注射器。

由於人們越來越偏好自行注射裝置，注射給藥裝置市場正在不斷成長。這些醫療設備允許患者在家中自行用藥，包括無針注射器、自動注射器、筆式注射器和穿戴式注射器。著名的例子包括 Becton、Dickinson and Company 的 BD Physioject，這是一種一次性自動注射器，專為慢性病患者自行注射藥物而設計。 Abbvie, Inc.、3M、Baxter、Gerresheimer AG 和 Pfizer Inc. 等公司是自行注射市場的積極參與者。自行注射藥物的好處和自我管理意識的提高增加了對此類設備的需求，推動了注射給藥設備市場的發展。

慢性病盛行率的不斷上升進一步推動了注射給藥裝置市場的成長。注射給藥裝置提供了一種方便可靠的方式來長期給藥、增強患者依從性並改善健康結果。美國國家生物技術資訊中心（NCBI）預測，全球慢性病人口將大幅增加，到2050年將達到1.4266億人。這種日益成長的盛行率是注射給藥裝置市場的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球注射給藥裝置市場，按類型、性能和預測細分，2018-2023、2023-2028、2033
  • 常規注射
  • 預填充式注射器
  • 自動注射器
  • 筆式注射器
  • 全球注射給藥裝置市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 自體免疫疾病
  • 荷爾蒙失調
  • 腫瘤學
  • 罕見疾病
  • 疼痛管理
  • 呼吸治療
  • 其他用途
  • 全球注射給藥設備市場，依最終用戶細分、績效與預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 家庭醫療保健設置
  • 製藥和生物技術公司
  • 研究
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球注射給藥裝置市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球注射給藥裝置市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 注射給藥裝置市場競爭形勢
  • 注射給藥裝置市場公司概況
    • Becton, Dickinson and Company
    • Baxter International
    • Gerresheimer AG
    • B. Braun Melsungen AG
    • Catalent, Inc.

第31章 其他大型創新公司

  • SkyePharma PLC
  • Antares Pharma
  • Pfizer Inc
  • GE Healthcare
  • Owen Mumford
  • Catalent Pharma Solutions
  • Philips
  • West Pharmaceutical Services, Inc.
  • Alkermes
  • Schott AG
  • UCB
  • AstraZeneca
  • Johnson &Johnson
  • NEARMEDIC PLUS LLC
  • Pendant Biosciences

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r14485

Injectable drug delivery devices serve multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $43.54 billion in 2023 to $47.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be attributed to the rapid growth in the elderly population, an increase in the number of healthcare facilities, rising healthcare expenditure, growth in biologics, and an increasing awareness of self-administration.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $61.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be attributed to factors such as the increasing prevalence of chronic diseases, a rising demand for injectable drugs, the sudden emergence of severe infections, and a large number of drugs and vaccines in various clinical trial stages. Notable trends expected in the forecast period include a focus on developing microneedle-based drug delivery systems, investment in the research and development of self-injectable devices, manufacturing of wearable devices, production of needle-free injection systems, expansion of product lines to include prefilled syringes, improvement of digital technology in devices, manufacturing of innovative devices, and emphasis on the production of innovative auto-injectors.

The injectable drug delivery devices market is experiencing growth driven by the increasing preference for self-injection devices. These medical devices enable patients to self-administer medication in a home setting and include needle-free, auto, pen, and wearable injectors. Notable examples include BD Physioject, a disposable auto-injector by Becton, Dickinson, and Company, designed for self-injection of drugs in chronic diseases. Companies such as Abbvie, Inc., 3M, Baxter, Gerresheimer AG, and Pfizer Inc. are actively participating in the self-injections market. The advantages of self-injectables and growing awareness of self-administration contribute to the rising demand for such devices, propelling the injectable drug delivery devices market.

The growth of the injectable drug delivery devices market is further fueled by the increasing prevalence of chronic diseases. Injectable drug delivery devices offer a convenient and reliable method for administering medications over extended periods, enhancing patient adherence and improving health outcomes. The National Center for Biotechnology Information (NCBI) projects a significant increase in the global population with chronic diseases, reaching 142.66 million by 2050. This escalating prevalence is a key driver for the injectable drug delivery devices market.

Manufacturers in the injectable drug delivery devices market are placing emphasis on auto-injectors, fully automated, customizable, and reusable devices. Auto-injectors provide patients with control over injection speed, minimizing pain or discomfort. Unilife Corporation's LISA, a reusable auto-injector, offers features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming. The technological advancements and new product launches in injectable drug delivery technology are expected to drive significant market growth.

Major companies in the self-injectable drug delivery devices market are innovating new products with enhanced safety systems to stay competitive. Advanced safety injectable drug delivery devices prioritize safe, effective, and reliable drug delivery subcutaneously or intravenously. West Pharmaceutical Services, Inc. launched the NovaGuard SA Pro Safety System, designed for use with prefilled ISO standard 0.5 mL and 1mL long staked-needle syringes. This safety system focuses on preventing needlestick injuries and incorporates features such as low snap-in force, prevention of pre-activation, low activation force for user comfort, and streamlined assembly. The device design simplifies glass pre-filled syringe assembly, reducing downtime and changeover time.

Major companies operating in the injectable drug delivery devices market report are Becton, Dickinson and Company, Baxter International, Gerresheimer AG, B. Braun Melsungen AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc., GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

North America was the largest region in the injectable drug delivery devices market in 2023. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Syringes; Injectors And Pump
  • 2) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 3) By End-user: Hospitals And Clinics; Home Healthcare Settings; Pharmaceutical And Biotechnological Companies; Research Laboratories; Other End Users
  • Sub segments: Conventional Injectable Devices; Pre-Filled Syringes; Auto-Injectors; Pen-Injectors; Insulin Pumps; Ambulatory Infusion Devices
  • Companies Mentioned: Becton, Dickinson and Company; Baxter International; Gerresheimer AG; B. Braun Melsungen AG; Catalent, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Drug Delivery Devices Market Characteristics

3. Injectable Drug Delivery Devices Market Trends And Strategies

4. Injectable Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Injectable Drug Delivery Devices Market Size and Growth

  • 5.1. Global Injectable Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Injectable Drug Delivery Devices Market Segmentation

  • 6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Conventional Injectable
  • Pre-filled Syringes
  • Auto-injectors
  • Pen-injectors
  • 6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare Settings
  • Pharmaceutical And Biotechnological Companies
  • Research Laboratories
  • Other End Users

7. Injectable Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Injectable Drug Delivery Devices Market

  • 8.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Injectable Drug Delivery Devices Market

  • 9.1. China Injectable Drug Delivery Devices Market Overview
  • 9.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Injectable Drug Delivery Devices Market

  • 10.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Injectable Drug Delivery Devices Market

  • 11.1. Japan Injectable Drug Delivery Devices Market Overview
  • 11.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Injectable Drug Delivery Devices Market

  • 12.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Injectable Drug Delivery Devices Market

  • 13.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Injectable Drug Delivery Devices Market

  • 14.1. South Korea Injectable Drug Delivery Devices Market Overview
  • 14.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Injectable Drug Delivery Devices Market

  • 15.1. Western Europe Injectable Drug Delivery Devices Market Overview
  • 15.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Injectable Drug Delivery Devices Market

  • 16.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Injectable Drug Delivery Devices Market

  • 17.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Injectable Drug Delivery Devices Market

  • 18.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Injectable Drug Delivery Devices Market

  • 19.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Injectable Drug Delivery Devices Market

  • 20.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Injectable Drug Delivery Devices Market

  • 21.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Injectable Drug Delivery Devices Market

  • 22.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Injectable Drug Delivery Devices Market

  • 23.1. North America Injectable Drug Delivery Devices Market Overview
  • 23.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Injectable Drug Delivery Devices Market

  • 24.1. USA Injectable Drug Delivery Devices Market Overview
  • 24.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Injectable Drug Delivery Devices Market

  • 25.1. Canada Injectable Drug Delivery Devices Market Overview
  • 25.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Injectable Drug Delivery Devices Market

  • 26.1. South America Injectable Drug Delivery Devices Market Overview
  • 26.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Injectable Drug Delivery Devices Market

  • 27.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Injectable Drug Delivery Devices Market

  • 28.1. Middle East Injectable Drug Delivery Devices Market Overview
  • 28.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Injectable Drug Delivery Devices Market

  • 29.1. Africa Injectable Drug Delivery Devices Market Overview
  • 29.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Injectable Drug Delivery Devices Market Competitive Landscape
  • 30.2. Injectable Drug Delivery Devices Market Company Profiles
    • 30.2.1. Becton, Dickinson and Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Baxter International
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Gerresheimer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. B. Braun Melsungen AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Catalent, Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. SkyePharma PLC
  • 31.2. Antares Pharma
  • 31.3. Pfizer Inc
  • 31.4. GE Healthcare
  • 31.5. Owen Mumford
  • 31.6. Catalent Pharma Solutions
  • 31.7. Philips
  • 31.8. West Pharmaceutical Services, Inc.
  • 31.9. Alkermes
  • 31.10. Schott AG
  • 31.11. UCB
  • 31.12. AstraZeneca
  • 31.13. Johnson & Johnson
  • 31.14. NEARMEDIC PLUS LLC
  • 31.15. Pendant Biosciences

32. Global Injectable Drug Delivery Devices Market Competitive Benchmarking

33. Global Injectable Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

35. Injectable Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Injectable Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Injectable Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Injectable Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer